NCT00853450 - Bleeding Time Study With AZD6482, Clopidogrel and ASA | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Study Completion Date

July 31, 2009

Conditions

Antiplatelet Effect

Interventions

DRUG

AZD6482

Single intravenous infusion during a maximum of 5 hours

DRUG

Clopidogrel

Oral doses given once daily during 7 days. 300 mg on day 1 and 75 mg on day 2 to 7.

DRUG

ASA

75 mg orally once daily during 7 days in each treatment arm

Trial Locations (1)

Research Site, Lund